Xuefang Liu
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Complementary and alternative medicine top 5%
- Topics
- Cancer-related molecular mechanisms research (14 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers)RNA modifications and cancer (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Xuefang Liu
101 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 737
- Cancer Research 441
- Pulmonary and Respiratory Medicine 283
- Immunology 129
- Complementary and alternative medicine 120
Countries citing papers authored by Xuefang Liu
This map shows the geographic impact of Xuefang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefang Liu more than expected).
Fields of papers citing papers by Xuefang Liu
This network shows the impact of papers produced by Xuefang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefang Liu. The network helps show where Xuefang Liu may publish in the future.
Co-authorship network of co-authors of Xuefang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xuefang Liu. A scholar is included among the top collaborators of Xuefang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefang Liu. Xuefang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 6 | |
| 10 | 26 | |
| 11 | 30 | |
| 12 | 9 | |
| 13 | 14 | |
| 14 | 1 | |
| 15 | 33 | |
| 16 | 11 | |
| 17 | 86 | |
| 18 | 3 | |
| 19 | 15 | |
| 20 | 19 |
About Xuefang Liu
Xuefang Liu is a scholar working on Complementary and alternative medicine, Life-span and Life-course Studies and Cancer Research, having authored 109 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (441 citations), Complementary and alternative medicine (120 citations) and Pharmacology (113 citations). Xuefang Liu has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Jiansheng Li, Peng Zhao, Suxiang Feng, Yange Tian, Jiancheng Tu, Ping Luo, Yanqin Qin, Xiaobo Feng, Chunzi Liang and Jing Wei. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.